Investors Ride 5 Healthcare Earnings Rollercoaster Rides

Hansen Medical, Inc. (NASDAQ:HNSN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.26 in the quarter versus EPS of $-0.20 in the year-earlier quarter. Revenue Decreased 36.56% to $2.95 million from the year-earlier quarter.

Hansen Medical, Inc. reported adjusted EPS loss of $0.26 per share. By that measure, the company missed the mean analyst estimate of $-0.13. It missed the average revenue estimate of $5.76 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

HNSN

LHC Group, Inc. (NASDAQ:LHCG) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 11.9% to $0.37 in the quarter versus EPS of $0.42 in the year-earlier quarter. Revenue Rose 2.04% to $162 million from the year-earlier quarter.

LHC Group, Inc. reported adjusted EPS income of $0.37 per share. By that measure, the company beat the mean analyst estimate of $0.33. It missed the average revenue estimate of $164.68 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

LHCG

OraSure Technologies Inc. (NASDAQ:OSUR) had a loss and met Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.18 in the quarter versus EPS of $-0.07 in the year-earlier quarter. Revenue Rose 1.24% to $21.2 million from the year-earlier quarter.

OraSure Technologies Inc. reported adjusted EPS loss of $0.18 per share. By that measure, the company met the mean analyst estimate of $-0.18. It beat the average revenue estimate of $20.82 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

OSUR

Avanir Pharmaceuticals (NASDAQ:AVNR) had a loss and missed Wall Street’s expectations, AND met the revenue expectation. Adjusted Earnings Per Share increased to $-0.12 in the quarter versus EPS of $-0.13 in the year-earlier quarter. Revenue Rose 73.31% to $17.4 million from the year-earlier quarter.

Avanir Pharmaceuticals reported adjusted EPS loss of $0.12 per share. By that measure, the company missed the mean analyst estimate of $-0.09. It met the average revenue estimate of $17.4 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

AVNR

Given Imaging Ltd. (NASDAQ:GIVN) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 500% to $0.06 in the quarter versus EPS of $0.01 in the year-earlier quarter. Revenue Decreased 2.96% to $40.6 million from the year-earlier quarter.

Given Imaging Ltd. reported adjusted EPS income of $0.06 per share. By that measure, the company missed the mean analyst estimate of $0.13. It missed the average revenue estimate of $44.63 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

GIVN

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , ,  

More from The Cheat Sheet